Financial Partners Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,610
| Closed | -$201K | – | 122 |
|
|
2022
Q2 | $201K | Buy |
2,610
+60
| +2% | +$4.61K | 0.04% | 118 |
|
|
2022
Q1 | $203K | Buy |
+2,550
| New | +$203K | 0.04% | 119 |
|
|
2018
Q4 | – | Sell |
-3,325
| Closed | -$214K | – | 86 |
|
|
2018
Q3 | $214K | Sell |
3,325
-350
| -10% | -$22.5K | 0.06% | 78 |
|
|
2018
Q2 | $217K | Sell |
3,675
-250
| -6% | -$14.8K | 0.07% | 76 |
|
|
2018
Q1 | $223K | Hold |
3,925
| – | – | 0.07% | 73 |
|
|
2017
Q4 | $233K | Buy |
+3,925
| New | +$233K | 0.04% | 115 |
|
|
2017
Q3 | – | Sell |
-3,409
| Closed | -$201K | – | 120 |
|
|
2017
Q2 | $201K | Sell |
3,409
-1,000
| -23% | -$59K | 0.04% | 112 |
|
|
2017
Q1 | $243K | Sell |
4,409
-50
| -1% | -$2.76K | 0.05% | 103 |
|
|
2016
Q4 | $234K | Sell |
4,459
-225
| -5% | -$11.8K | 0.06% | 101 |
|
|
2016
Q3 | $260K | Hold |
4,684
| – | – | 0.07% | 91 |
|
|
2016
Q2 | $275K | Hold |
4,684
| – | – | 0.07% | 85 |
|
|
2016
Q1 | $269K | Sell |
4,684
-595
| -11% | -$34.2K | 0.07% | 93 |
|
|
2015
Q4 | $345K | Sell |
5,279
-200
| -4% | -$13.1K | 0.08% | 106 |
|
|
2015
Q3 | $345K | Sell |
5,479
-100
| -2% | -$6.3K | 0.09% | 105 |
|
|
2015
Q2 | $395K | Sell |
5,579
-125
| -2% | -$8.85K | 0.1% | 101 |
|
|
2015
Q1 | $401K | Sell |
5,704
-125
| -2% | -$8.79K | 0.1% | 96 |
|
|
2014
Q4 | $375K | Sell |
5,829
-200
| -3% | -$12.9K | 0.1% | 97 |
|
|
2014
Q3 | $383K | Hold |
6,029
| – | – | 0.11% | 89 |
|
|
2014
Q2 | $374K | Sell |
6,029
-100
| -2% | -$6.2K | 0.11% | 92 |
|
|
2014
Q1 | $358K | Sell |
6,129
-50
| -0.8% | -$2.92K | 0.12% | 94 |
|
|
2013
Q4 | $328K | Sell |
6,179
-33
| -0.5% | -$1.75K | 0.11% | 93 |
|
|
2013
Q3 | $297K | Hold |
6,212
| – | – | 0.12% | 80 |
|
|
2013
Q2 | $282K | Buy |
+6,212
| New | +$282K | 0.13% | 81 |
|